HKD 7.66
(-1.42%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 21.82 Million USD | 117.67% |
2022 | -123.53 Million USD | 10.38% |
2021 | -137.83 Million USD | 53.52% |
2020 | -296.53 Million USD | -339.67% |
2019 | -67.44 Million USD | -81.6% |
2018 | -37.13 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -102.5 Thousand USD | -101.15% |
2024 Q2 | -102.5 Thousand USD | 0.0% |
2023 Q4 | 8.9 Million USD | 2.91% |
2023 Q2 | 2 Million USD | 0.0% |
2023 Q3 | 8.65 Million USD | 330.58% |
2023 FY | 21.82 Million USD | 117.67% |
2023 Q1 | 2 Million USD | 107.96% |
2022 FY | -123.53 Million USD | 10.38% |
2022 Q4 | -25.24 Million USD | 0.0% |
2022 Q3 | -25.24 Million USD | 29.28% |
2022 Q2 | -35.69 Million USD | 0.0% |
2022 Q1 | -35.69 Million USD | 22.48% |
2021 Q4 | -46.04 Million USD | 0.0% |
2021 Q3 | -46.04 Million USD | -80.92% |
2021 Q1 | -25.45 Million USD | 30.42% |
2021 FY | -137.83 Million USD | 53.52% |
2021 Q2 | -25.45 Million USD | 0.0% |
2020 Q4 | -36.57 Million USD | 0.0% |
2020 Q2 | -7.36 Million USD | 0.0% |
2020 Q1 | -7.36 Million USD | 33.62% |
2020 FY | -296.53 Million USD | -339.67% |
2020 Q3 | -36.57 Million USD | -396.97% |
2019 Q3 | -11.08 Million USD | 32.98% |
2019 FY | -67.44 Million USD | -81.6% |
2019 Q4 | -11.08 Million USD | 0.0% |
2019 Q2 | -16.54 Million USD | 0.0% |
2019 Q1 | -16.54 Million USD | 0.0% |
2018 FY | -37.13 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 67.76 Million HKD | 67.792% |
CK Life Sciences Int'l., (Holdings) Inc. | 897.95 Million HKD | 97.569% |